Regeneron Pharmaceuticals (REGN) Revenue Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 122.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.94% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.47% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 54.05% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.47% |
| Dec 31, 2025 | 238.67% |
| Sep 30, 2025 | 8.54% |
| Jun 30, 2025 | 8.76% |
| Mar 31, 2025 | 292.73% |
| Dec 31, 2024 | -8.53% |
| Sep 30, 2024 | 2.52% |
| Jun 30, 2024 | -11.62% |
| Mar 31, 2024 | 7.54% |
| Dec 31, 2023 | 12.33% |
| Sep 30, 2023 | 13.60% |
| Jun 30, 2023 | 17.39% |
| Mar 31, 2023 | 20.04% |
| Dec 31, 2022 | -62.28% |
| Sep 30, 2022 | 18.97% |
| Jun 30, 2022 | 21.89% |
| Mar 31, 2022 | -66.85% |
| Dec 31, 2021 | 36.95% |
| Sep 30, 2021 | 27.56% |
| Jun 30, 2021 | 47.29% |
| Mar 31, 2021 | 18.71% |
| Dec 31, 2020 | 15.26% |
| Sep 30, 2020 | 15.19% |
| Jun 30, 2020 | 9.91% |
| Mar 31, 2020 | 11.50% |
| Dec 31, 2019 | 14.95% |
| Sep 30, 2019 | 12.64% |
| Jun 30, 2019 | 9.17% |
| Mar 31, 2019 | 4.56% |
| Dec 31, 2018 | 20.64% |
| Sep 30, 2018 | 13.51% |
| Jun 30, 2018 | 17.21% |
| Mar 31, 2018 | 20.23% |
| Dec 31, 2017 | 25.41% |
| Sep 30, 2017 | 27.40% |
| Jun 30, 2017 | 30.22% |
| Mar 31, 2017 | 28.22% |
| Dec 31, 2016 | 26.20% |
| Sep 30, 2016 | 26.90% |
| Jun 30, 2016 | 38.38% |
| Mar 31, 2016 | 39.78% |
| Dec 31, 2015 | 38.36% |
| Sep 30, 2015 | 38.55% |
| Jun 30, 2015 | 48.59% |
| Mar 31, 2015 | 55.39% |
| Dec 31, 2014 | 86.86% |
| Sep 30, 2014 | 91.82% |
| Jun 30, 2014 | 83.46% |
| Mar 31, 2014 | 77.34% |
| Dec 31, 2013 | 265.46% |
| Sep 30, 2013 | 394.55% |
| Jun 30, 2013 | 58.06% |
| Mar 31, 2013 | 515.45% |
| Dec 31, 2012 | 216.03% |
| Sep 30, 2012 | 53.85% |
| Jun 30, 2012 | 307.45% |